Literature DB >> 12197148

Open dialogues with good and poor outcomes for psychotic crises: examples from families with violence.

Jaakko Seikkula1.   

Abstract

In Open Dialogue the first treatment meeting occurs within 24 hr after contact and includes the social network of the patient. The aim is to generate dialogue to construct words for the experiences embodied in the patient's psychotic symptoms. All issues are analyzed and planned with everyone present. A dialogical sequence analysis was conducted comparing good and poor outcomes of first-episode psychotic patients. In good outcomes, the clients had both interactional and semantic dominance, and the dialogue took place in a symbolic language and in a dialogical form. Already at the first meeting, in the good outcome cases, the team responded to the client's words in a dialogical way, but in the case with the poor outcome, the patient's reflections on his own acts were not heard.

Entities:  

Mesh:

Year:  2002        PMID: 12197148     DOI: 10.1111/j.1752-0606.2002.tb01183.x

Source DB:  PubMed          Journal:  J Marital Fam Ther        ISSN: 0194-472X


  4 in total

1.  Open Dialogue and its Relevance to the NHS: Opinions of NHS Staff and Service Users.

Authors:  Russell Razzaque; Lisa Wood
Journal:  Community Ment Health J       Date:  2015-02-17

2.  How Can Poetry Support the Understanding of Psychotic Experiences? - A Conceptual Review.

Authors:  Mark Pearson; Stefan Rennick-Egglestone; Gary Winship
Journal:  J Recovery Ment Health       Date:  2020 Winter-Spring

3.  Experiences of a transdiagnostic group, the Take Control Course, for clients with common mental health problems: A qualitative study.

Authors:  Lydia Morris; Warren Mansell; Rebekah Amos; Dawn Edge
Journal:  Clin Psychol Psychother       Date:  2018-06-26

4.  Nothing matters: the significance of the unidentifiable, the superficial and nonsense.

Authors:  Tore Dag Bøe; Inger Beate Larsen; Alain Topor
Journal:  Int J Qual Stud Health Well-being       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.